#BEGIN_DRUGCARD DB02034

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
72741-87-8

# ChEBI_ID:
Not Available

# Chemical_Formula:
C8H15NO3

# Chemical_IUPAC_Name:
(1S,2R,8S,8aS)-octahydroindolizine-1,2,8-triol

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
An indolizidine alkaloid from the plant Swainsona canescens that is a potent alpha-mannosidase inhibitor. Swainsonine also exhibits antimetastatic, antiproliferative, and immunomodulatory activity. [PubChem]

# Dosage_Forms:
Not Available

# Drug_Category:
Adjuvants, Immunologic
Antineoplastic Agents, Phytogenic
Enzyme Inhibitors

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Swainsonine

# HET_ID:
SWA

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C8H15NO3/c10-5-2-1-3-9-4-6(11)8(12)7(5)9/h5-8,10-12H,1-4H2/t5-,6+,7-,8+/m0/s1

# InChI_Key:
InChIKey=FXUAIOOAOAVCGD-FKSUSPILSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C10173

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2034

# Mechanism_Of_Action:
Not Available

# Melting_Point:
143-144 Â°C

# Molecular_Weight_Avg:
173.2096

# Molecular_Weight_Mono:
173.105193351

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1HWW

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-1.5

# Predicted_LogS:
0.88

# Predicted_Water_Solubility:
1.32e+03 g/l

# Primary_Accession_No:
DB02034

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
10975968

# PubChem_Substance_ID:
46506581

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02983

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
O[C@@H]1CN2CCC[C@H](O)[C@H]2[C@@H]1O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:44 -0700

# Wikipedia_Link:
http://en.wikipedia.org/wiki/Swainsonine

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Golgi apparatus membrane

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
MAN2A1

# Drug_Target_1_GenBank_ID_Gene:
D63998

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
MAN2A1

# Drug_Target_1_Gene_Sequence:
Not Available

# Drug_Target_1_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_1_General_References:
8524845	Misago M, Liao YF, Kudo S, Eto S, Mattei MG, Moremen KW, Fukuda MN: Molecular cloning and expression of cDNAs encoding human alpha-mannosidase II and a previously unrecognized alpha-mannosidase IIx isozyme. Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11766-70.

# Drug_Target_1_HGNC_ID:
HGNC:6824

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
5983

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
131142

# Drug_Target_1_Name:
Alpha-mannosidase 2

# Drug_Target_1_Number_of_Residues:
1144

# Drug_Target_1_PDB_ID:
Not Available

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF01074	Glyco_hydro_38
PF07748	Glyco_hydro_38C
PF09261	Alpha-mann_mid

# Drug_Target_1_Protein_Sequence:
>Alpha-mannosidase 2
MKLSRQFTVFGSAIFCVVIFSLYLMLDRGHLDYPRNPRREGSFPQGQLSMLQEKIDHLER
LLAENNEIISNIRDSVINLSESVEDGPKSSQSNFSQGAGSHLLPSQLSLSVDTADCLFAS
QSGSHNSDVQMLDVYSLISFDNPDGGVWKQGFDITYESNEWDTEPLQVFVVPHSHNDPGW
LKTFNDYFRDKTQYIFNNMVLKLKEDSRRKFIWSEISYLSKWWDIIDIQKKDAVKSLIEN
GQLEIVTGGWVMPDEATPHYFALIDQLIEGHQWLENNIGVKPRSGWAIDPFGHSPTMAYL
LNRAGLSHMLIQRVHYAVKKHFALHKTLEFFWRQNWDLGSVTDILCHMMPFYSYDIPHTC
GPDPKICCQFDFKRLPGGRFGCPWGVPPETIHPGNVQSRARMLLDQYRKKSKLFRTKVLL
APLGDDFRYCEYTEWDLQFKNYQQLFDYMNSQSKFKVKIQFGTLSDFFDALDKADETQRD
KGQSMFPVLSGDFFTYADRDDHYWSGYFTSRPFYKRMDRIMESHLRAAEILYYFALRQAH
KYKINKFLSSSLYTALTEARRNLGLFQHHDAITGTAKDWVVVDYGTRLFHSLMVLEKIIG
NSAFLLILKDKLTYDSYSPDTFLEMDLKQKSQDSLPQKNIIRLSAEPRYLVVYNPLEQDR
ISLVSVYVSSPTVQVFSASGKPVEVQVSAVWDTANTISETAYEISFRAHIPPLGLKVYKI
LESASSNSHLADYVLYKNKVEDSGIFTIKNMINTEEGITLENSFVLLRFDQTGLMKQMMT
KEDGKHHEVNVQFSWYGTTIKRDKSGAYLFLPDGNAKPYVYTTPPFVRVTHGRIYSEVTC
FFDHVTHRVRLYHIQGIEGQSVEVSNIVDIRKVYNREIAMKISSDIKSQNRFYTDLNGYQ
IQPRMTLSKLPLQANVYPMTTMAYIQDAKHRLTLLSAQSLGVSSLNSGQIEVIMDRRLMQ
DDNRGLEQGIQDNKITANLFRILLEKRSAVNTEEEKKSVSYPSLLSHITSSLMNHPVIPM
ANKFSSPTLELQGEFSPLQSSLPCDIHLVNLRTIQSKVGNGHSNEAALILHRKGFDCRFS
SKGTGLFCSTTQGKILVQKLLNKFIVESLTPSSLSLMHSPPGTQNISEINLSPMEISTFR
IQLR

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Catalyzes the first committed step in the biosynthesis of complex N-glycans. It controls conversion of high mannose to complex N-glycans; the final hydrolytic step in the N-glycan maturation pathway

# Drug_Target_1_SwissProt_ID:
Q16706

# Drug_Target_1_SwissProt_Name:
MA2A1_HUMAN

# Drug_Target_1_Synonyms:
Alpha-mannosidase II
EC 3.2.1.114
Golgi alpha- mannosidase II
MAN II
Mannosidase alpha class 2A member 1
Mannosyl- oligosaccharide 1,3-1,6-alpha-mannosidase

# Drug_Target_1_Theoretical_pI:
7.61

# Drug_Target_1_Transmembrane_Regions:
6-26

#END_DRUGCARD DB02034
